![]() |
市场调查报告书
商品编码
1304504
全球短链果寡糖(scFOS)市场 - 2023-2030年Global Short-chain Fructooligosaccharides (scFOS) Market - 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
全球短链果寡糖(scFOS)市场规模在2022年达到5.705亿美元,预计到2030年将达到12.318亿美元。在2023-2030年的预测期内,该市场的复合年增长率为10.1%。
随着人们越来越认识到肠道微生物群在整体健康中的作用,消化健康已成为消费者关注的重点领域。ScFOS作为益生元,可滋养和促进肠道有益菌的生长,支持健康的肠道微生物群组成。ScFOS可作为益生菌(促进肠道健康的有益菌)的营养来源。
在产品中将ScFOS与益生菌结合使用,可通过支持益生菌菌株的存活和生长而提供协同效益。ScFOS可作为功能性配料应用于各种食品和饮料产品中。ScFOS可被添加到各种配方中,包括乳制品、烘焙食品、谷物、饮料和营养补充剂,以增强其营养成分并提供额外的健康益处。
科学研究揭示了肠道微生物群在维持消化系统健康和整体健康中的关键作用。肠道细菌的组成和多样性影响人体健康的各个方面,包括消化、免疫功能和心理健康。作为一种益生元成分,scFOS可选择性地促进肠道有益菌的生长,从而对肠道微生物群的组成产生积极影响,并有助于消化系统的健康。根据美国国家医学图书馆(National Library of Medicine)的研究,在摄入2.5和5克/天剂量的scFOS时,腹胀会明显加剧,但在摄入7.5和10克/天剂量时,腹胀不会加剧。
肠易激综合征(IBS)和炎症性肠病(IBD)等消化系统疾病在全球越来越普遍。因此,人们对有助于控制这些疾病和促进消化系统健康的食品和饮料产品的需求日益增长。具有益生元特性的ScFOS提供了一种天然的解决方案,有可能缓解症状并改善肠道功能。近年来,肠道健康在整体健康中的重要性得到了广泛关注。消费者越来越意识到健康的肠道微生物群与各方面健康之间的联系,包括消化、免疫功能甚至心理健康。
COVID-19分析包括COVID前情景、COVID情景和COVID后情景,以及价格动态(包括大流行期间和大流行后的价格变化,并与COVID前情景进行比较)、供求关系(由于贸易限制、封锁和后续问题而导致的供求变化)、政府倡议(政府机构为振兴市场、部门或行业而采取的倡议)和制造商战略倡议(制造商为缓解COVID问题而采取的措施)。
The Global Short-Chain Fructooligosaccharides (scFOS) market reached US$ 570.5 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 1,231.8 million by 2030. The market is growing at a CAGR of 10.1% during the forecast period 2023-2030.
Digestive health has become a key area of focus for consumers, with increasing recognition of the role of gut microbiota in overall wellness. ScFOS, as prebiotics, nourish and promote the growth of beneficial gut bacteria, supporting a healthy gut microbiota composition. ScFOS can act as a source of nutrients for probiotics, the beneficial bacteria that promote gut health.
Combining scFOS with probiotics in products can provide synergistic benefits by supporting the survival and growth of probiotic strains. ScFOS find applications as functional ingredients in various food and beverage products. They can be incorporated into a wide range of formulations, including dairy products, baked goods, cereals, beverages, and nutritional supplements, to enhance their nutritional profile and provide additional health benefits.
Scientific research has uncovered the critical role of gut microbiota in maintaining digestive health and overall well-being. The composition and diversity of gut bacteria influence various aspects of human health, including digestion, immune function, and mental health. As a prebiotic ingredient, scFOS selectively promotes the growth of beneficial gut bacteria, which can positively impact the gut microbiota composition and contribute to digestive health. According to the National Library of Medicine, Bloating was significantly more intense during scFOS ingestion at doses of 2.5 and 5 g/d, but not at doses of 7.5 and 10 g/d.
Digestive disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are becoming more prevalent globally. As a result, there is a growing demand for food and beverage products that can help manage these conditions and promote digestive wellness. ScFOS, with its prebiotic properties, offers a natural solution that can potentially alleviate symptoms and improve gut function. The importance of gut health in overall wellness has gained significant attention in recent years. Consumers are becoming more aware of the link between a healthy gut microbiome and various aspects of health, including digestion, immune function, and even mental well-being.
The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).
The global short-chain fructooligosaccharides market is segmented based on source, form, application, and region.
Short-chain fructooligosaccharides (scFOS) find extensive applications in the food and beverages industry. They are used as functional ingredients in various products, including dairy products, baked goods, cereals, beverages, and nutritional supplements. The versatility of scFOS and their compatibility with different food matrices make them popular among food and beverage manufacturers.
There is a growing consumer demand for functional foods and beverages that offer additional health benefits beyond basic nutrition. Functional ingredients like scFOS, known for their prebiotic properties and potential health benefits, are highly sought after by health-conscious consumers. The food and beverages segment responds to this demand by incorporating scFOS into its product formulations.
North America has experienced a growing demand for functional ingredients in the food and beverage industry. Consumers are increasingly seeking products that offer additional health benefits beyond basic nutrition. This demand has driven the incorporation of functional ingredients like scFOS into a wide range of food and beverage products. The North American population has shown an increased focus on health and wellness.
Consumers are becoming more aware of the importance of maintaining a healthy diet and lifestyle. As a result, there is a growing interest in products that support digestive health, weight management, and overall well-being. ScFOS, known for its prebiotic properties and potential health benefits, align with this health-conscious trend.
The major global players include: the Short-chain Fructooligosaccharides (scFOS) market are Beneo-Orafti, Jarrow Formulas Inc., Sensus B.V., Tata Sons Private Limited, Galam, Cosucra Groupe Warcoing SA, Tereos, CJ Cheiljedang Corp., Ingredion, and Meiji Food Materia Co., Ltd.
The global short-chain fructooligosaccharides market report would provide approximately 61 tables, 57 figures, and 200 pages.
LIST NOT EXHAUSTIVE